Water/Wastewater
Five year agreement with world?s fifth largest wastewater company
Aug 10 2009
Bluewater Bio International has signed a five year binding agreement with Aqualia Gestiόn Integral del Agua S.A. (“aqualia”), a subsidiary of global infrastructure giant Grupo FCC that manages water and wastewater related projects in over 850 municipalities on five continents, serving over 26 million people.
Bluewater Bio has developed a revolutionary proprietary technology, Hybrid Bacillus Activated Sludge (“HYBACS”), a biological wastewater treatment process that is odourless and that produces a high quality, re-usable effluent. HYBACS reduces operational expense, primarily electricity consumption, by up to 50%. Furthermore, due to its compact modular footprint, HYBACS can either halve the land requirement or increase the treatment capacity of an existing works, thereby significantly reducing build cost. Pedro Rodríguez, Technical Director of aqualia, said: “Following nine months of close cooperation, including visits to numerous operational sites to see HYBACS in action, we are delighted to be formalising the partnership between aqualia and Bluewater Bio. The Company provides a technology that fulfils both our economic criteria for reduced capital and operational expenditure, whilst also reducing energy, chemical and carbon footprint. Bluewater Bio can help us respond to pressing issues such as water scarcity, climate change, population growth and compliance with ever-tightening environmental regulations.“ Under the agreement, Bluewater Bio will install a proprietary HYBACS plant at a municipal site in Avila. The plant will be operated by aqualia, using the Company‟s HYBACS wastewater treatment process for enhanced nutrient control at a land-constrained facility. The plant will be installed at the site within 8-10 weeks, whereupon commissioning will commence. Fernando Moreno, Director General of aqualia, said: “As a leading global company in the water sector we have to make a considerable effort in technology innovation so that we can adapt to the ever more demanding requirements of legislation and customers. The agreement that we have just signed with Bluewater, with which we are very satisfied, fulfils our strategy of incorporating the most advanced technologies for waste water treatment.”Daniel Ishag, CEO of Bluewater Bio added: “With global population set to grow from seven billion today to nine billion by 2040, the resulting economic, regulatory and environmental pressures are becoming ever-more stark and the commercial opportunities increasingly attractive. HYBACS can help global companies such as aqualia conserve our most valuable resource, water, by removing harmful pollutants and increasing its re-use in applications such as irrigation and air conditioning projects. Indeed we are already working with aqualia to develop HYBACS as a platform for just such schemes across major markets including the Middle East, in some parts of which a barrel of water is already more valuable than a barrel of oil.
Events
Apr 18 2024 Shanghai, China
Apr 22 2024 Hannover, Germany
Apr 23 2024 Kuala Lumpur, Malaysia
Apr 24 2024 Sao Paulo, Brasil
May 05 2024 Seville, Spain
